YCW24· OtherParcelBio
Elevated mRNA for transformative medicines.
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Sensible BiotechnologiesS21Unlocking the next generation of mRNA medicinesShared: synthetic biology, biotech, therapeuticsActive
Engage BioW22Potent, durable, and redosable non-viral genetic medicinesShared: synthetic biology, biotech, therapeuticsAcquired
SynsoryBioW24"If-then" conditional logic for protein drugsShared: synthetic biology, biotech, therapeuticsActive
Velorum TherapeuticsW24Breakthrough medicines unlocking the biology of hemeShared: biotech, therapeutics, drug discoveryActive
Cisterna BiologicsS22High quality mRNA for therapeutic applicationShared: synthetic biology, biotech, therapeuticsActive
Adjacent
Overlapping tags, a different niche.
Kopra BioS24Genetically engineered viruses that teach your immune system to kill…Shared: gene therapy, synthetic biology, biotechActive
Origami Therapeutics, Inc.W22Oral drugs to halt neurodegenerationShared: biotech, therapeutics, drug discoveryActive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotech, therapeutics, drug discoveryActive
Granza BioW24Building programmable therapeutics for the immune systemShared: synthetic biology, biotech, therapeuticsActive
Modulari-TW23We teach your immune system to attack and cure cancerShared: gene therapy, synthetic biology, biotechActive
Also from W24
Batchmates in Winter 2024.
Tamarind BioW24AI Inference Platform for Drug DiscoveryActive
AbelW24Transforming document review for litigation teamsInactive
AdaptedW24AI physical therapy for athletesActive
AedilicW24Open-Source AI-generated image/deepfake detectionInactive
AftercareW24Conversational AI surveys with intelligent follow-up questionsActive
Agentic LabsW24AI system design tools for dev teamsActive
About ParcelBio
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
San Francisco, CA, USA
ParcelBio: questions
Which YC batch was ParcelBio in?
ParcelBio was in Y Combinator's Winter 2024 batch (W24).
Is ParcelBio still active?
Y Combinator lists ParcelBio as active.
Where is ParcelBio based?
ParcelBio lists San Francisco, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.